{"id":"W2950269753","doi":"10.1097/01.hs9.0000560680.23378.f5","title":"PF598 STEM CELL YIELD AND TRANSPLANTATION IN TRANSPLANT‐ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING DARATUMUMAB + BORTEZOMIB/THALIDOMIDE/DEXAMETHASONE (D‐VTD): PHASE 3 CASSIOPEIA STUDY","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Plerixafor; Multiple myeloma; Autologous stem-cell transplantation; Internal medicine; Daratumumab; Transplantation; Surgery; Bortezomib; Oncology; CXCR4","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001767286,0.0005569933,0.001033582,0.0002368847,0.000303783,0.0005934081,0.0003631765,0.0006465498,0.001337339],"category_scores_gemma":[0.001003564,0.0002609922,0.0008104302,0.0002673373,0.0004864476,0.0004231722,0.000369531,0.001284508,0.0002639626],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005589622,"about_ca_system_score_gemma":0.000702244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003769723,"about_ca_topic_score_gemma":0.0006308119,"domain_scores_codex":[0.999568,0.0002062358,0.0000280032,0.00007690734,0.00005721039,0.00006359253],"domain_scores_gemma":[0.9990387,0.000191746,0.0002621872,0.00005594017,0.00003465873,0.0004167554],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6638306,0.01841793,0.2224663,0.0002171096,0.001588459,0.0002661163,0.0002948172,0.00201538,0.02798431,0.0001522565,0.001768003,0.06099883],"study_design_scores_gemma":[0.130895,0.4104443,0.4397467,0.00004644686,0.001765289,0.000971924,0.0001365865,0.004289431,0.008935514,0.0002914447,0.00242964,0.00004768477],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993655,0.0002990008,0.00004409749,0.00004495373,0.00001050898,0.00004778828,0.00008145287,0.000004416156,0.0001023503],"genre_scores_gemma":[0.9991195,0.0001315608,0.0001184071,0.0001168255,0.00003696882,0.00007444308,0.0002717914,0.000002271979,0.0001283035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001767286,"threshold_uncertainty_score":0.009346426,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02467029566795772,"score_gpt":0.2923307548691387,"score_spread":0.267660459201181,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}